Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-16
1999-12-07
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548468, A61K 3140, C07D40306
Patent
active
059984627
ABSTRACT:
Described herein are compounds selective for the 5-HT.sub.1D -like receptor, which have the general formula: ##STR1## wherein: R.sup.1 is linear or branched loweralkyl;
REFERENCES:
patent: 4870085 (1989-09-01), Glaser et al.
patent: 5348968 (1994-09-01), Lavielle et al.
patent: 5496957 (1996-03-01), Glennon
patent: 5504101 (1996-04-01), Glennon
Glen, et al. Journal of Medicinal Chemistry, 1995, 38:3566-3580. "Computer-Aided Design and Synthesis of 5-Substituted Tryptamines and Their Pharmacology at the 5-HT1D Receptor: Discovery of Compounds with Potential Anti-Migraine Properties".
Chemical Abstracts, vol. 97, No. 17, Oct., 1982, abs. No. 144720k, Banglun et al. "Synthesis of N,N-disubstituted beta-hydroxy-tryptamines."
Macor, John, A direct synthesis of 3-(pyrrolidin-3-yl)indoles for Use as Conformationally Restricted Analogs of Tryptamines (Apr., 1997), pp. 443-449, Synthesis.
Edwards Louise
Meng Qingchang
Rakhit Sumanas
Slassi Abdelmalik
Allelix Biopharmaceuticals Inc.
Morris Patricia L.
LandOfFree
5-alkyl indole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-alkyl indole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-alkyl indole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824477